rs782426283

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001110556.2(FLNA):​c.4232C>T​(p.Ser1411Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000199 in 1,209,922 control chromosomes in the GnomAD database, including 1 homozygotes. There are 125 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S1411S) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000062 ( 0 hom., 5 hem., cov: 24)
Exomes 𝑓: 0.00021 ( 1 hom. 120 hem. )

Consequence

FLNA
NM_001110556.2 missense

Scores

1
10
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:4

Conservation

PhyloP100: 1.16

Publications

2 publications found
Variant links:
Genes affected
FLNA (HGNC:3754): (filamin A) The protein encoded by this gene is an actin-binding protein that crosslinks actin filaments and links actin filaments to membrane glycoproteins. The encoded protein is involved in remodeling the cytoskeleton to effect changes in cell shape and migration. This protein interacts with integrins, transmembrane receptor complexes, and second messengers. Defects in this gene are a cause of several syndromes, including periventricular nodular heterotopias (PVNH1, PVNH4), otopalatodigital syndromes (OPD1, OPD2), frontometaphyseal dysplasia (FMD), Melnick-Needles syndrome (MNS), and X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
FLNA Gene-Disease associations (from GenCC):
  • periventricular nodular heterotopia
    Inheritance: AD, XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • frontometaphyseal dysplasia 1
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • heterotopia, periventricular, X-linked dominant
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Illumina
  • intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Melnick-Needles syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • otopalatodigital syndrome type 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • terminal osseous dysplasia-pigmentary defects syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • cardiac valvular dysplasia, X-linked
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • frontometaphyseal dysplasia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital short bowel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • otopalatodigital syndrome type 1
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Ehlers-Danlos syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: XL Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.038050085).
BP6
Variant X-154359317-G-A is Benign according to our data. Variant chrX-154359317-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 435207.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000621 (7/112702) while in subpopulation SAS AF = 0.00108 (3/2788). AF 95% confidence interval is 0.000292. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 24. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 5 XL,AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLNANM_001110556.2 linkc.4232C>T p.Ser1411Leu missense_variant Exon 25 of 48 ENST00000369850.10 NP_001104026.1
FLNANM_001456.4 linkc.4232C>T p.Ser1411Leu missense_variant Exon 25 of 47 NP_001447.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLNAENST00000369850.10 linkc.4232C>T p.Ser1411Leu missense_variant Exon 25 of 48 1 NM_001110556.2 ENSP00000358866.3

Frequencies

GnomAD3 genomes
AF:
0.0000621
AC:
7
AN:
112702
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.0000967
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00108
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000359
AC:
65
AN:
181241
AF XY:
0.000460
show subpopulations
Gnomad AFR exome
AF:
0.0000809
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.000224
GnomAD4 exome
AF:
0.000213
AC:
234
AN:
1097220
Hom.:
1
Cov.:
33
AF XY:
0.000330
AC XY:
120
AN XY:
363132
show subpopulations
African (AFR)
AF:
0.0000758
AC:
2
AN:
26398
American (AMR)
AF:
0.0000284
AC:
1
AN:
35205
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19385
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30206
South Asian (SAS)
AF:
0.00392
AC:
212
AN:
54145
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39661
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4133
European-Non Finnish (NFE)
AF:
0.0000107
AC:
9
AN:
842004
Other (OTH)
AF:
0.000195
AC:
9
AN:
46083
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000621
AC:
7
AN:
112702
Hom.:
0
Cov.:
24
AF XY:
0.000143
AC XY:
5
AN XY:
34848
show subpopulations
African (AFR)
AF:
0.0000967
AC:
3
AN:
31035
American (AMR)
AF:
0.00
AC:
0
AN:
10744
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2663
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3582
South Asian (SAS)
AF:
0.00108
AC:
3
AN:
2788
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6222
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53223
Other (OTH)
AF:
0.00
AC:
0
AN:
1519
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000298
Hom.:
1
Bravo
AF:
0.0000945
ExAC
AF:
0.000487
AC:
59

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Nov 17, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 20, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Heterotopia, periventricular, X-linked dominant Pathogenic:1
Sep 26, 2019
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Jul 02, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Benign:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 14, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 20598277, 28454995) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.78
D;.;.;.;.
FATHMM_MKL
Benign
0.30
N
LIST_S2
Uncertain
0.95
D;D;.;D;D
M_CAP
Pathogenic
0.69
D
MetaRNN
Benign
0.038
T;T;T;T;T
MetaSVM
Uncertain
0.22
D
MutationAssessor
Uncertain
2.3
M;.;M;M;.
PhyloP100
1.2
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-4.2
D;.;D;D;.
REVEL
Uncertain
0.44
Sift
Uncertain
0.0020
D;.;D;D;.
Sift4G
Uncertain
0.0030
D;D;D;D;D
Polyphen
0.95
P;.;P;P;.
Vest4
0.24
MutPred
0.53
Gain of catalytic residue at S1411 (P = 0.0016);.;Gain of catalytic residue at S1411 (P = 0.0016);Gain of catalytic residue at S1411 (P = 0.0016);.;
MVP
0.90
MPC
0.68
ClinPred
0.095
T
GERP RS
5.5
Varity_R
0.51
gMVP
0.69
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782426283; hg19: chrX-153587685; API